Updated on 15 June 2012
In South Korea, about 40 companies have created market capitalization of over $14.96 billion. Medipost from South Korea, with sales revenue of $55 million, has good market potential as its market cap stands at $673 million. Similarly, Seegene ($35.46 million), Komipharm International ($18.27 million) and MedyTox ($19.53 million) generated fair amount of interest among investors through their R&D initiatives. These companies have market capitalization of $495 million, $399.6 million and $223.47 million, respectively.
In India, the companies whose revenues are over $1 billion and are into research and development, manufacturing and marketing of life-saving products have market capitalization of over $1 billion. In all, 15 companies are above the $1 billion mark.